Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yonghong Song

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Biosafety and Health|March 13, 2025
Molecular epidemiological study on tick-borne pathogens in Qinghai Province, Northwestern ChinaChunfeng Luo, Yonghong Song, Luoyuan Xia, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Design, synthesis and structure-activity relationships of benzoxazinone-based factor Xa inhibitorsWenrong Huang, Penglie Zhang, Jingmei F Zuckett, et al.
Science (New York, N.Y.)|February 26, 2016
A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in miceEric M Green, Hiroko Wakimoto, Robert L Anderson, et al.
Nature Nanotechnology|January 22, 2020
Regioselective magnetization in semiconducting nanorodsTao-Tao Zhuang, Yi Li, Xiaoqing Gao, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
N,N-Dialkylated 4-(4-arylsulfonylpiperazine-1-carbonyl)-benzamidines and 4-((4-arylsulfonyl)-2-oxo-piperazin-1-ylmethyl)-benzamidines as potent factor Xa inhibitorsZhaozhong J Jia, Ting Su, Jingmei F Zuckett, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2002
Design, synthesis, and SAR of substituted acrylamides as factor Xa inhibitorsYonghong Song, Lane Clizbe, Chhaya Bhakta, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2009
Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitorPenglie Zhang, Wenrong Huang, Lingyan Wang, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Biosafety and Health|March 13, 2025
Molecular epidemiological study on tick-borne pathogens in Qinghai Province, Northwestern ChinaChunfeng Luo, Yonghong Song, Luoyuan Xia, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Design, synthesis and structure-activity relationships of benzoxazinone-based factor Xa inhibitorsWenrong Huang, Penglie Zhang, Jingmei F Zuckett, et al.
Science (New York, N.Y.)|February 26, 2016
A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in miceEric M Green, Hiroko Wakimoto, Robert L Anderson, et al.
Nature Nanotechnology|January 22, 2020
Regioselective magnetization in semiconducting nanorodsTao-Tao Zhuang, Yi Li, Xiaoqing Gao, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
N,N-Dialkylated 4-(4-arylsulfonylpiperazine-1-carbonyl)-benzamidines and 4-((4-arylsulfonyl)-2-oxo-piperazin-1-ylmethyl)-benzamidines as potent factor Xa inhibitorsZhaozhong J Jia, Ting Su, Jingmei F Zuckett, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2002
Design, synthesis, and SAR of substituted acrylamides as factor Xa inhibitorsYonghong Song, Lane Clizbe, Chhaya Bhakta, et al.
Bioorganic & Medicinal Chemistry Letters|March 20, 2009
Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitorPenglie Zhang, Wenrong Huang, Lingyan Wang, et al.
Pageof 6